Table 2. Stratification factors.
| Number (%) | P *value | mTTP (months) | 95% CI | P# value | |||
|---|---|---|---|---|---|---|---|
| PS | 0 | CS group | 28(23.33%) | 0.57 | 5.54 | 4.33-8.16 | 0.87 |
| CF group | 29(25.00%) | 4.20 | 2.75-10.46 | ||||
| 1 | CS group | 85(70.83%) | 5.64 | 4.20-6.30 | 0.64 | ||
| CF group | 83(71.55%) | 5.05 | 4.00-6.56 | ||||
| 2 | CS group | 7(5.84%) | 4.41 | 3.39-5.62 | 0.84 | ||
| CF group | 4(3.45%) | 4.61 | 3.36-5.20 | ||||
| Numbers of metastasis | 1 | CS group | 18(15.00%) | 0.91 | 6.26 | 3.61-8.52 | 0.2 |
| CF group | 18(15.52%) | 5.64 | 4.00-6.26 | ||||
| >1 | CS group | 102(85.00%) | 5.25 | 4.33-6.26 | 0.63 | ||
| CF group | 98(84.48%) | 4.33 | 3.90-5.87 | ||||
| Gastrectomy | No | CS group | 65(54.17%) | 0.88 | 5.25 | 4.23-6.26 | 0.86 |
| CF group | 64(55.17%) | 4.20 | 3.90-6.10 | ||||
| Yes | CS group | 55(45.83%) | 5.77 | 4.33-7.57 | 0.95 | ||
| CF group | 52(44.83%) | 5.05 | 3.70-9.97 | ||||
TTP: Time to progression
CS: cisplatin and S-1; CF: cisplatin and fluorouracil
*
The comparison of patients in different stratification factors
#
The comparison of TTP for patients in CS and CF groups.